Jul 13, 2026
Guggenheim Ups Eli Lilly (LLY) Price Target to $1,273 on Pipeline Strength
Guggenheim raises Eli Lilly (LLY) price target to $1,273, citing strong tirzepatide growth and retatrutide pipeline potential. Q2 earnings expected August 5.
The post Guggenheim Ups Eli Lilly (LLY) Price Target to $1,273 on Pipeline Strength appeared first on Blockonomi.
Source: Blockonomi →Related News
- 48 minutes ago
Take-Two Interactive (TTWO) Stock Falls 2% Despite Beating Q1 Estimates Amid GTA...
- 55 minutes ago
Software Sector Rally: Atlassian (TEAM) Soars 30% While Trade Desk (TTD) Plunges...
- 56 minutes ago
Weak July Jobs Report Fuels Stock Market Rally on Fed Rate Cut Speculation
- 57 minutes ago
Twilio (TWLO) Stock Jumps 16% After Smashing Q2 Earnings and Boosting Annual Gui...
- 58 minutes ago
Akamai (AKAM) Soars 13% Following Massive $600M AI Robotics Agreement
